AEHR TEST SYSTEMS (AEHR): Submission of Matters to a Vote of Security Holders

AEHR TEST SYSTEMS (AEHR) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. Item 5.07. Submission of Matters to a Vote of Security Holders. The Annual Meeting of shareholders of Aehr Test Systems (the “Company”) was held on October 19, 2026 (the “Annual Meeting”). There were 32,659,546 shares of common stock entitled to vote at the Annual Meeting and 22,

Original reporting
Published Oct 20, 2026, 9:04 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 20, 2026, 9:08 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$AEHR
Neutral
high confidence
Mentioned
$AEHR
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$AEHRNeutralLow
01

Why it matters

The filing confirms the status quo; no new financial data or strategic initiatives were announced.

02

Market read

Low relevance for traders; the filing is a standard governance update with minimal price impact.

03

What to watch

Potential hidden proxy battles or dissenting votes are not disclosed in the summary.

Relevance 6/10Novelty 3/10Timing: filing date Oct 20 2026

Background

AEHR Test Systems filed an 8‑K to disclose the outcomes of its annual shareholders meeting, a routine corporate governance filing.

Company-level read

Ticker impact

$AEHRNeutralHigh confidence
Context

SEC Form 8‑K reports the annual meeting results, including election of six directors, auditor ratification and advisory compensation approval.

Expected impact

likely little impact as the market has already priced the routine governance outcomes.

Evidence & confidence

Annual meeting results are standard disclosures; no new strategic moves or financial guidance were provided.

Market effects

None; governance updates do not affect the broader semiconductor test equipment sector.

None; the filing is company‑specific and does not influence regional markets.

None; no global macro or sector‑wide implications.

Counterpoint

If the newly elected directors bring unexpected strategic shifts, the stock could react, but no such signals are present.

Key entities

  • AEHR Test Systems

    US‑listed provider of test and handling equipment for semiconductor manufacturers.

Related articles

$AEHRHighAI 9/10

Aehr Test Systems (AEHR) (Q1 2027) Earnings Call Highlights: Record Revenue, Raised

Aehr Test Systems (AEHR) reported record Q1 2027 revenue of $33M and raised annual guidance to $150M. CEO Gayn Erickson highlighted a potential large burn-in opportunity, estimating $35M-$70M in revenue per million units shipped. The company expects sequential growth in remaining quarters, with Q4 potentially the highest. Management confirmed they are not supply-constrained and can ship more than guided. Silicon carbide revenue was about $10M in fiscal 2026, with expectations for growth in 2027.

$AEHRHighAI 9/10

AEHR Stock Surges After Massive AI-Driven Earnings Beat

Aehr Test Systems (AEHR) stock rose 26.6% after reporting Q1 FY27 revenue of $33M, up 300% year-over-year and 75% quarter-over-quarter. Adjusted EPS was $0.28, beating estimates. The company raised FY27 revenue guidance to $150M, citing strong demand for AI and power semiconductor testing.

$AEHRHighAI 9/10

Aehr Stock Jumps 16% After Bookings Hit $46.7 Million

Aehr Test Systems (AEHR) shares rose 16.38% premarket after its Q1 revenue tripled to $33.0M, beating estimates. The company raised its full-year outlook to $150M, citing strong bookings and backlog growth. CEO Gayn Erickson highlighted a major AI customer opportunity. According to GuruFocus, there are 6 warning signs with AEHR.

$AEHRHighAI 8/10

Why is Aehr Test Systems stock surging today?

Aehr Test Systems (AEHR) stock surged 18.8% in pre-market trading after reporting record Q1 2027 revenue of $33.0M, up 200% YoY, and raising full-year revenue outlook to $150M. Non-GAAP net income was $9.4M, or $0.28 per share, exceeding analyst estimates. The company cited strong demand for AI semiconductor test solutions and a book-to-bill ratio of 1.4.

$AEHRMed

Aehr stock jumps on beat and raise amid AI demand

Aehr Test Systems (AEHR) shares rose 15% after reporting Q1 revenue of $33M, up 200% YoY, and raising its FY2027 outlook to $150M. The company cited strong demand for its semiconductor testing systems used in AI chips. CEO Gayn Erickson noted a conservative approach to the revised target. Bookings were $46.7M with a book-to-bill ratio of 1.4.